Art

J-GLOBAL ID：200902246690175038   Reference number：03A0189749

Improvement of Right Heart Function by Sarpogrelate Hydrochloride in Patients with Secondary Pulmonary Hypertension.

二次肺高血圧症患者における塩酸サルポグレラートによる右心機能の改善

Author (4)： KATO S (Dokkyo Univ. School of Medicine) ,  OGAWA K (Dokkyo Univ. School of Medicine) ,  KISHIRO I (Dokkyo Univ. School of Medicine) ,  KANEKO N (Dokkyo Univ. School of Medicine)
Material： 日本臨床生理学会雑誌  (Journal of Clinical Physiology)
Volume： 33  Issue： 1  Page： 21-27  Publication year： Feb. 01, 2003 
JST Material Number： Y0689A  ISSN： 0286-7052  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *pulmonary hypertension ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0189749&from=J-GLOBAL&jstjournalNo=Y0689A") }}

JST classification (2)： Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Sarpogrelate hydrochloride

Reference (23)：

• KANAI, Y. Role of 5-hydroxytryptamine in the progression of monocrotaline-induced pulmonary hypertension in rat. Cardiovasc Res. 1993, 27, 1619-1623
• HERVE, P. Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995, 99, 249-254
• BREUER, J. Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease. Pediatr Cardiol. 1996, 17, 214-219
• MAC LEAN, MR. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol. 1996, 119, 917-930
• KEREVEUR, A. High plasma serotonin levels in primary pulmonary hypertension : Effect of long-term epoprostenal (prostacyclin) therapy. Arterioscler Thromb Vasc Biol. 2000, 20, 2233-2239

Terms in the title (4)： 肺高血圧症 ,  患者 ,  塩酸サルポグレラート ,  右心機能